PANTHERNA THERAPEUTICS
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium. Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany.
PANTHERNA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
Hennigsdorf, Brandenburg, Germany
Country:
Germany
Website Url:
http://www.pantherna-therapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+49(0)3302-202 240-0
Email Addresses:
[email protected]
Total Funding:
3.5 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Microsoft Exchange Online Office 365 Mail
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
MC2 Therapeutics
MC2 Therapeutics is a privately held emerging pharmaceutical company.
Pentraxin Therapeutics
Pentraxin Therapeutics is a University College London spin out company founded in 2001
PTC Therapeutics Sweden AB
PTC Therapeutics Sweden AB is a Therapeutics and Pharmaceuticals company.
Current Employees Featured
Founder
Investors List
European Investment Fund
European Investment Fund investment in Seed Round - Pantherna Therapeutics
Detlev Riesner
Detlev Riesner investment in Seed Round - Pantherna Therapeutics
High-Tech Grunderfonds
High-Tech Grunderfonds investment in Seed Round - Pantherna Therapeutics
Official Site Inspections
http://www.pantherna-therapeutics.com
- Host name: 178.16.61.39
- IP address: 178.16.61.39
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Pantherna Therapeutics"
Pantherna Therapeutics - Crunchbase Company Profile & Funding
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on …See details»
Translation - Pantherna Therapeutics
Pantherna Therapeutics is a privately-held biopharmaceutical company developing advanced nanoparticle solutions for the delivery and expression of mRNA ... With PAN004 Pantherna …See details»
Pantherna Therapeutics GmbH - Hennigsdorf, Germany
Jan 13, 2022 Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna's innovative technology …See details»
Team - Pantherna Therapeutics
Pantherna Therapeutics is a privately-held biopharmaceutical company developing advanced nanoparticle solutions for the delivery and expression of mRNA therapeutics. ... At Pantherna …See details»
PAN-004 - Drug Targets, Indications, Patents - Synapse
About Pantherna Pantherna Therapeutics is a privately held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna's innovative technology …See details»
Pantherna Therapeutics (Pantherna Therapeutics GmbH) - Startbase
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on …See details»
Pantherna Therapeutics - PitchBook
Pantherna Therapeutics General Information Description. Operator of a biopharmaceutical company intended to develop therapeutics for vascular diseases. The company offers a …See details»
Pantherna Therapeutics GmbH - VentureRadar
Pantherna Therapeutics is a privately-held biopharmaceutical company founded in 2014 and developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology …See details»
Pantherna Therapeutics GmbH - LinkedIn
Pantherna Therapeutics is a privately held mRNA therapeutics company developing novel first-in-class therapies for indications with high unmet medical need.See details»
Pantherna Therapeutics • life science startup - HTGF
The life science start-up Pantherna Therapeutics secures €3.5 million in a successful seed-financing round. The start-up presents a proprietary, innovative technology platform for the …See details»
PAN-007 - Drug Targets, Indications, Patents - Synapse - Patsnap
6 days ago PAN-007: a Tie-2 modulators Drug, Initially developed by Pantherna Therapeutics GmbH, Now, its global highest R&D status is Discontinued, Mechanism: Tie-2 modulators(TEK …See details»
Astellas and Pantherna Enter into a New Technology Evaluation …
Oct 3, 2022 About Pantherna Pantherna Therapeutics is a privately held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna's innovative …See details»
Technology - Pantherna Therapeutics
Pantherna has developed cutting-edge genetic therapeutics through its PTXmRNA® and PTXΔLNP® technologies. PTXmRNA® is a proprietary technology by Pantherna, …See details»
News | Astellas Pharma Inc.
Oct 4, 2022 TOKYO and Hennigsdorf, Germany, October 4, 2022 - Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pantherna …See details»
Astellas and Pantherna Enter into a New Technology Evaluation …
Oct 3, 2022 Pantherna Therapeutics was recently awarded with a 2022 Pharma Trend Honor for its lead candidate PAN004 in the category "Most Innovative Product: Leap Innovations-Nucleic …See details»
04 Oct - Pantherna Therapeutics
Oct 4, 2022 Pantherna Therapeutics is a privately held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is …See details»
Press Release - Astellas Pharma
Oct 4, 2022 About Pantherna Pantherna Therapeutics is a privately held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative …See details»
“First-in-Class“ mRNA-therapeutics for vascular diseases: …
The life science start-up Pantherna Therapeutics secures €3.5 million in a successful seed-financing round. The start-up presents a proprietary, innovative technology platform for the …See details»
News | Astellas Pharma Inc.
Nov 15, 2021 TOKYO and Hennigsdorf, Germany, November 15, 2021 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pantherna …See details»